Answers are grounded in this paper and cite their sources.
Immunohistochemistry reveals strong HIF-1α and erythropoietin expression in superficial esophageal carcinoma, highlighting angiogenesis implications.
Background/Aim: Hypoxia-inducible factor 1α (HIF-1α) plays a significant role in angiogenesis; however, few studies have examined its expression in superficial esophageal carcinoma. This study examined the timing at which the hypoxia-induced angiogenesis switch is turned on by investigating the expression of HIF-1α and its downstream target, erythropoietin (Epo), in superficial esophageal carcinoma. Materials and Methods: We used 53 lesions of superficial esophageal carcinoma and conducted immunohistochemistry for HIF-1α and Epo. Cases were divided into three groups: T1a-EP/LPM group (22 lesions), T1a-MM/T1b-SM1 group (15 lesions), and T1b-SM2,3 group (16 lesions). HIF-1α and Epo expression levels were compared across groups using H scores. Additionally, in 24 cases with intraepithelial spread, expression was compared between intraepithelial and invasive components. Results: Both HIF-1α and Epo were most strongly expressed in T1a-EP/LPM, with significantly reduced expression observed in tumors that invaded the muscularis mucosae or deeper layers. A strong positive correlation was found between HIF-1α and Epo expression scores. HIF-1α and Epo values were significantly higher in the intraepithelial area than in the invaded area. Conclusion: In esophageal carcinoma, HIF-1α and Epo were strongly expressed at the earliest stages of carcinogenesis. As the carcinoma progressed beyond the muscularis mucosae, the expression of these markers significantly declined, suggesting a resolution of hypoxia likely associated with active angiogenesis.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: